Current Oncology Reports

Article	Citations
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review	156
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain	153
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer	110
New Developments in VHL-Associated Neuroendocrine Neoplasms	105
Management of Upper Tract Urothelial Carcinoma	77
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	69
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas	60
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers	56
Treatment of Metastatic Melanoma in the Elderly	46
Immunotherapy in Biliary Tract Cancers: Where Are We?	46
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review	45
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors	40
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances	39
Fatty Acid Metabolism and Cancer Immunotherapy	39
Brain Prehabilitation for Oncologic Surgery	38
NRG1 Fusions: The New Kid on the Block	37
Surgical Management of Melanoma: Advances and Updates	37
Management of In-Transit Metastases	36
Current Trends and Challenges of Microbiome Research in Prostate Cancer	34
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients	34
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients	34
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan	32
Head and Neck Mucosal Melanoma: Where Are We Now?	32
Cellular Therapy in NSCLC: Between Myth and Reality	31
The Microbiome in Advanced Melanoma: Where Are We Now?	31

Anti-PD-1: When to Stop Treatment	30
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting	30
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications	29
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites	29
Surgical Stress and Cancer Progression: New Findings and Future Perspectives	28
The Difficult Airway in Patients with Cancer	28
An Overview of Angiogenesis in Bladder Cancer	27
AXL Inhibitors: Status of Clinical Development	27
Engineered T Cells: CAR T Cell Therapy and Beyond	27
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review	26
Proton Therapy in The Treatment of Head And Neck Cancers- Review	26
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?	26
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations	26
Targeting the PI3K Pathway in Gynecologic Malignancies	25
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours	24
What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?	24
Appendiceal Neuroendocrine Neoplasms: an Update for 2023	24
Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors	24
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy	24
CAR-T Therapies in Solid Tumors: Opportunities and Challenges	23
Cancer Pain Management—New Therapies	23
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question	22
Surgery for Recurrent Epithelial Ovarian Cancer	22
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review	22
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer	22
Treatments on the Horizon: Breast Cancer Patients with Central Nervous System Metastases	22
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews	22
Pitfalls and Successes in Trials in Older Transplant Patients with Hematologic Malignancies	22
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations	22
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma	22
Development of Effective Siglec-9 Antibodies Against Cancer	22
Critical Review of the Current Evidence on Sentinel Node Biopsy in Oral Cancer	21
Current Management of Neuroendocrine Tumour Liver Metastases	21
Geographical Disparities in Colorectal Cancer in Canada: A Review	21
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)	20
Vascular Inflammation, Cancer, and Cardiovascular Diseases	20
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing	20
Evolving Treatment Approaches to Mucosal Melanoma	20
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials	19
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions	19
Controversies in the Treatment of Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia	18
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets	18
Helping Patients Understand and Cope with BRCA Mutations	18
Small Cell and Other Rare Histologic Types of Cervical Cancer	18
Rehabilitation in Advanced Cancer Patients with Bone Metastases and Neural Compromise: Current Status and Future Directions	17
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging	17
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer	17
Elderly Rectal Cancer: An Updated Review	17
Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction	17
Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic	17

Management of Peripheral T-cell Lymphomas and the Role of Transplant	17
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?	17
Current Diagnostic Tools for Breast Cancer-Related Lymphedema	17
Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity	17
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review	16
History of Leukemia, Revisited	16
Ependymoma: Evaluation and Management Updates	16
Statins for Cardiac and Vascular Protection During and After Cancer Therapy	16
Multimodality Therapies for Localized Prostate Cancer	16
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review	16
Intratumoral Immunotherapy: Is It Ready for Prime Time?	16
Current Status on Management of Primary Plasma Cell Leukemia	16
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives	15
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy	15
Epidemiology of Cancer in Older Adults: A Systematic Review	15
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours	15
Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review	15
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers	15
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge	15
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights	15
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment	15
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development	14
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade	14
Is Myelodysplasia a Consequence of Normal Aging?	14
Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies	14
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis	14
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma	14
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions	14
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL	14
Bystander effect of antibody–drug conjugates: fact or fiction?	14
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment	14
Richter’s Transformation	14
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy	14
Return to Intended Oncological Therapy: State of the Art and Perspectives	14
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer	13
The Role and Impact of Minimal Residual Disease in NSCLC	13
All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations	13
CDK4/6 inhibitors: The Devil is in the Detail	13
Racial Disparities in Breast Cancer: from Detection to Treatment	13
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas	13
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?	13
Interventional Strategies in Cancer-induced Cardiovascular Disease	13
Viral and Clinical Oncology of Head and Neck Cancers	13
Clinicopathological Review of Micropapillary Urothelial Carcinoma	12
CAR T-cell Therapy for Central Nervous System Lymphoma	12
Cardio-Oncology in Childhood: State of the Art	12
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science	12
Surviving Burnout as an Oncologist	12
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer	12
Current Role of Functional Imaging in the Management of Lymphoma	12
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer	12
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine	12
Advances in Treatment of Waldenström Macroglobulinemia	12
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis	12
Lymphatic Interventions in the Cancer Patient	12
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway	12
Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer	12
Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity	12
Epidemiology of cancer in older adults: a systematic review of age-related differences in solid malignancies treatment	12
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes	11
Integrative Geriatric Oncology: A Review of Current Practices	11
Rehabilitation Needs for Patients Undergoing CAR T-Cell Therapy	11
Current Issues in Treatment of Parotid Gland Cancer and Advanced Surgical Technique of Robotic Parotidectomy	11
New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors	11
State of Rehabilitation Research in the Head and Neck Cancer Population: Functional Impact vs. Impairment-Focused Outcomes	11
Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers	11
Fertility-Sparing and Less Radical Surgery for Cervical Cancer	11
Perioperative Blood Transfusions and Cancer Progression: A Narrative Review	11
BTK Inhibitors and CAR T-Cell Therapy in Treating Mantle Cell Lymphoma—Finding a Dancing Partner	11
Defining The Role for Hormone Therapy in Biochemically Recurrent Prostate Cancer: What Counts as a Win for Patients?	11
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab	11
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?	11
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism	11
Chronodisruption and Ambulatory Circadian Monitoring in Cancer Patients: Beyond the Body Clock	11
Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy	11
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from Taiwan	11
Percutaneous Ablation of T1b Renal Cell Carcinoma: An Overview	10
Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?	10
Managing Pain and Discomfort in Children with Cancer	10
Intracranial Germinomas: Diagnosis, Pathogenesis, Clinical Presentation, and Management	10

Pelvic Floor Therapy and Initial Interventions for Pelvic Floor Dysfunction in Gynecologic Malignancies	10
COVID-19 in Children with Cancer	10
Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions	10
Exercise as Medicine in Cardio-Oncology: Reducing Health Disparities in Hispanic and Latina Breast Cancer Survivors	10
Correction to: Postmastectomy Functional Impairments	10
Post-acute Care Needs and Benefits of Inpatient Rehabilitation Care for the Oncology Patient	10
Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm	10
Oral Complications and Management Strategies for Cancer Patients: Principles of Supportive Oncology in Dentistry	9
Adjuvant Therapy in Node-Positive Endometrial Cancer: A Focus on Chemotherapy	9
Toxicities from BRAF and MEK Inhibitors: Strategies to Maximize Therapeutic Success	9
Germline Mutations and Ancestry in Prostate Cancer	9
Targeting Apoptosis in Cancer	9
Perceptions, Knowledge, and Attitudes of General Population About Prostate Cancer-Associated Risk Factors: A Systematic Review of Qualitative Studies Focusing on Lifestyle	9
An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism	9
Clinical Applications and Advancements of Positron Emission Tomography/Computed Tomography in Cardio-Oncology: A Comprehensive Literature Review and Emerging Perspectives	9
Oligometastatic Esophagogastric Cancer: Does It Exist and How Do We Treat It?	9
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach	9
The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies	9
Disparities in Lung Cancer Treatment	9
Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice	9
Asparaginase: How to Better Manage Toxicities in Adults	9
Prostate Cancer, Pathophysiology and Recent Developments in Management: A Narrative Review	9
Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis	9
Novel Insights of Anti-EGFR Therapy in HNSCC: Combined with Immunotherapy or Not?	8
Melanoma in Pediatric and Young Adult Patients	8
The Microbiome’s Influence on Head and Neck Cancers	8
Beneath the Surface: The Emerging Role of Ultra-Processed Foods in Obesity-Related Cancer	8
Radiation and Melanoma: Where Are We Now?	8
Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to Bedside	8
Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors	8
Evolving Strategies in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Esophagogastric Adenocarcinoma	8
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths	8
ChatGPT in Oncology Diagnosis and Treatment: Applications, Legal and Ethical Challenges	8
Cell-free Tumor DNA: a Promising Technology for Diagnosis, Surveillance and Therapeutic Decision in Urothelial Carcinoma of the Bladder	8
Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors	8
Liver Cancer Etiology: Old Issues and New Perspectives	8
Targeted Therapy for Melanomas Without BRAF V600 Mutation	8
Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients	8
Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology	8
Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy	8
25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions	8
Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science	8
Hairy Cell Leukemia: Where Are We in 2023?	8
Effect of Post-diagnosis Physical Activity on Breast Cancer Recurrence: a Systematic Review and Meta-analysis	8
The Role of Hyperthermia in the Treatment of Peritoneal Surface Malignancies	8
Correction to: Past, Present, and Future Therapeutic Strategies for NF‑1‑Associated Tumors	8
Integrative Oncology Approaches to Reduce Recurrence of Disease and Improve Survival	8
Older Patients with Lung Cancer: a Summary of Seminal Contributions to Optimal Patient Care	7
Ablation of Kidney Tumors in Patients with Substantial Kidney Impairment: Current Status	7
Recent Progress in Mind–Body Therapies in Cancer Care	7
Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?	7
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment	7
Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients	7
Chemokine Receptor Antagonists: Role in Oncology	7
Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review	7
De-escalation for Human Papillomavirus-Positive Oropharyngeal Cancer: A Look at the Prospective Evidence	7
Current Issues in Fertility Preservation Among Pediatric and Adolescent Cancer Patients	7
Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges	7
Update on Percutaneous Ablation for Sarcoma	7
Cardiac Arrhythmias in Oncological Patients—Epidemiology, Risk Factors, and Management within the Context of the New ESC 2022 Guidelines	7
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer	7
Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment	7
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)	7
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature	7
Palliative Care in Paediatric Oncology: an Update	7
Postoperative Delirium and Neurocognitive Disorders: Updates for Providers Caring for Cancer Patients	7
Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma	7
Optimal Use of Tumor-Based Molecular Assays for Localized Prostate Cancer	6
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?	6
Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances	6
Percutaneous Management of Breast Cancer: a Systematic Review	6
Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group	6
Cardiotoxicities of Non-Chemotherapeutic Metastatic Breast Cancer Treatments	6
Current Trends and Challenges of Microbiome Research in Bladder Cancer	6
Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review	6
Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management	6
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned	6
Easing the Journey—an Updated Review of Palliative Care for the Patient with High-Grade Glioma	6
Metronomic Chemotherapy in Elderly Patients	6
Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship	6
Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment	6
Immunotherapy Versus Hospice: Treatment Decision-Making in the Modern Era of Novel Cancer Therapies	6
Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?	6
Chemotherapy-Induced Peripheral Neuropathy: Diagnosis, Agents, General Clinical Presentation, and Treatments	6
Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma	6
Treatment Strategy for Elderly Patients with Soft Tissue Sarcoma	6
Non-squamous Cancers of the Larynx	6
Surgery in the Era of Immunotherapy for Advanced Head and Neck Non-melanoma Skin Cancer	6
Enhanced Recovery After Surgery (ERAS) in Surgical Oncology	6
Emerging Therapeutic Targets of Neuroendocrine Prostate Cancer	6
Aromatase Inhibitor Musculoskeletal Syndrome and Bone Loss: a Review of the Current Literature	6
Molecular Testing in Gliomas: What is Necessary in Routine Clinical Practice?	6
Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape	6
Translocations and Gene Fusions in Sinonasal Malignancies	6
Novel Clinical PET Tracers in the Pipeline for Melanoma	6